| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.44 | 1e-14 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-08 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.38 | 2e-07 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.37 | 2e-07 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-06 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-05 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0007 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |